Anavex Life Sciences Corp (AVXL)

[vg_future]

Bright/interesting tidbits from this morning's PR

From PR:
- Meeting with FDA for discussing ANAVEX®2-73 Parkinson’s disease program including pivotal Phase 3 study.

(please note the "Meeting" word as opposed to "Planned to meet"...so, this is actively happening now...hopefully more color will be provided during the CC this evening.

- Cash and cash equivalents of $153.3 million on March 31, 2022

(cash and cash equivalents were at 151.1 million at the end of Dec, 2021....so that is an increase of 2.2 million in spite of burn rate of 10.9 million roughly...effectively making it a 13.1 million increase in cash...revenue, grant or otherwise)

There are other highlights as well, but these 2 caught my eye.

Good luck to the long shareholders.

-vg_future